Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Operations

v3.22.1
Consolidated Statements of Operations - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Revenue    
Product revenue, net $ 63,134 $ 44,531
Collaboration revenue 5,389 0
Revenue - related party 268 1,068
Net revenue 68,791 45,599
Operating expenses    
Cost of goods sold - product revenue 32,084 14,594
Research and development 113,240 61,275
Research and development - licenses acquired 15,625 2,834
Selling, general and administrative 86,843 61,166
Wire transfer fraud loss 9,540  
Total operating expenses 257,332 139,869
Loss from operations (188,541) (94,270)
Other income (expense)    
Interest income 649 1,518
Interest expense and financing fee (15,308) (15,326)
Change in fair value of investments 39,294 6,418
Change in fair value of derivative liability (447) (1,189)
Total other income (expense) 24,188 (8,579)
Loss before income tax expense (164,353) (102,849)
Income tax expense 473 136
Net loss (164,826) (102,985)
Net loss attributable to non-controlling interests 100,123 56,459
Net loss attributable to common stockholders $ (64,703) $ (46,526)
Net loss per common share - basic and diluted $ (2.02) $ (1.43)
Net loss per common share attributable to non - controlling interests - basic and diluted (1.23) (0.78)
Net loss per common share attributable to common stockholders - basic and diluted $ (0.79) $ (0.65)
Weighted average common shares outstanding - basic and diluted 81,700,220 72,005,181